| Product Code: ETC9959522 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Artemisinin Combination Therapy Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Artemisinin Combination Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Artemisinin Combination Therapy Market - Industry Life Cycle |
3.4 United States (US) Artemisinin Combination Therapy Market - Porter's Five Forces |
3.5 United States (US) Artemisinin Combination Therapy Market Revenues & Volume Share, By Combination Therapy Type, 2021 & 2031F |
4 United States (US) Artemisinin Combination Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of malaria in the United States |
4.2.2 Growing awareness about the effectiveness of artemisinin combination therapy |
4.2.3 Government initiatives to combat malaria and promote the use of artemisinin combination therapy |
4.3 Market Restraints |
4.3.1 High cost associated with artemisinin combination therapy |
4.3.2 Limited availability and access to artemisinin combination therapy drugs |
4.3.3 Potential side effects and resistance issues with prolonged use of artemisinin combination therapy |
5 United States (US) Artemisinin Combination Therapy Market Trends |
6 United States (US) Artemisinin Combination Therapy Market, By Types |
6.1 United States (US) Artemisinin Combination Therapy Market, By Combination Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Artemisinin Combination Therapy Market Revenues & Volume, By Combination Therapy Type, 2021- 2031F |
6.1.3 United States (US) Artemisinin Combination Therapy Market Revenues & Volume, By Artemether-Lumefantrine, 2021- 2031F |
6.1.4 United States (US) Artemisinin Combination Therapy Market Revenues & Volume, By Artesunate-Amodiaquine, 2021- 2031F |
6.1.5 United States (US) Artemisinin Combination Therapy Market Revenues & Volume, By Artesunate-Pyronaridine, 2021- 2031F |
6.1.6 United States (US) Artemisinin Combination Therapy Market Revenues & Volume, By Artesunate-Sulfadoxine-Pyrimethamine, 2021- 2031F |
6.1.7 United States (US) Artemisinin Combination Therapy Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Artemisinin Combination Therapy Market Import-Export Trade Statistics |
7.1 United States (US) Artemisinin Combination Therapy Market Export to Major Countries |
7.2 United States (US) Artemisinin Combination Therapy Market Imports from Major Countries |
8 United States (US) Artemisinin Combination Therapy Market Key Performance Indicators |
8.1 Number of diagnosed malaria cases in the United States |
8.2 Adoption rate of artemisinin combination therapy among healthcare providers |
8.3 Research and development investments in improving artemisinin combination therapy formulations |
9 United States (US) Artemisinin Combination Therapy Market - Opportunity Assessment |
9.1 United States (US) Artemisinin Combination Therapy Market Opportunity Assessment, By Combination Therapy Type, 2021 & 2031F |
10 United States (US) Artemisinin Combination Therapy Market - Competitive Landscape |
10.1 United States (US) Artemisinin Combination Therapy Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Artemisinin Combination Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |